Reaction Details |
| Report a problem with these data |
Target | Somatostatin receptor type 3 |
---|
Ligand | BDBM50400528 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_879797 (CHEMBL2210525) |
---|
IC50 | 7.3±n/a nM |
---|
Citation | He, S; Ye, Z; Truong, Q; Shah, S; Du, W; Guo, L; Dobbelaar, PH; Lai, Z; Liu, J; Jian, T; Qi, H; Bakshi, RK; Hong, Q; Dellureficio, J; Pasternak, A; Feng, Z; deJesus, R; Yang, L; Reibarkh, M; Bradley, SA; Holmes, MA; Ball, RG; Ruck, RT; Huffman, MA; Wong, F; Samuel, K; Reddy, VB; Mitelman, S; Tong, SX; Chicchi, GG; Tsao, KL; Trusca, D; Wu, M; Shao, Q; Trujillo, ME; Eiermann, GJ; Li, C; Zhang, BB; Howard, AD; Zhou, YP; Nargund, RP; Hagmann, WK The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes. ACS Med Chem Lett3:484-489 (2012) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Somatostatin receptor type 3 |
---|
Name: | Somatostatin receptor type 3 |
Synonyms: | SOMATOSTATIN SST3 | SS-3-R | SS3-R | SS3R | SSR-28 | SSR3_HUMAN | SSTR3 | Somatostatin receptor type 3 (SSTR3) |
Type: | Protein |
Mol. Mass.: | 45855.97 |
Organism: | Homo sapiens (Human) |
Description: | P32745 |
Residue: | 418 |
Sequence: | MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLL
GNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVM
AVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVV
FSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRV
WAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVA
LPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEE
SREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
|
|
|
BDBM50400528 |
---|
n/a |
---|
Name | BDBM50400528 |
Synonyms: | CHEMBL2204934 |
Type | Small organic molecule |
Emp. Form. | C32H25FN4 |
Mol. Mass. | 484.5661 |
SMILES | Fc1ccc(cc1)-c1c[nH]c(n1)[C@H]1Cc2c([nH]c3ccccc23)C(N1)(c1ccccc1)c1ccccc1 |r| |
Structure |
|